|
Dear <<First Name>>,
I hope this message finds you well and enjoying the holiday season.
What a year it’s been at the Castleman Disease Collaborative Network (CDCN) and the Center for Cytokine Storm Treatment & Laboratory (CSTL), as we celebrate 10 years of lifesaving research! Because of your support, we continue to turn hope into action through our relentless research to identify effective treatments and cures for Castleman disease (CD), as well as COVID-19 and other related diseases. We hope we can count on you once again during this season of giving.
I'd like to share a few highlights of our work in 2022 that you have helped make possible.
|
|
|
We invite you to learn more about these accomplishments and others in our most recent report.
|
|
We are so very thankful for our amazing leadership team, Scientific Advisory Board, Board of Directors, Advisory Council, volunteers, patients, loved ones, and our extraordinary community of donors and supporters. Without all of you, the work we do simply isn't possible.
On a personal note, I'm preparing to celebrate nine years in remission this January! When I became ill in 2010, I never could have imagined the scientific progress we would make through the CDCN and the CSTL, the collaborative spirit of our brilliant medical community, the personal milestones that I would be able to experience, and that so many CD patients are experiencing, or the celebration of our 10th anniversary! If you have a few minutes, please check out the anniversary video below, which we shared at our annual gala in November. It's quite inspiring!
|
|
|
The CDCN means so much to so many. We’re making a profound difference in the lives of CD patients who are responding to treatments we’ve identified and helped to advance, where none existed before. But about one-half of patients still do not respond to the only FDA-approved drug currently available, siltuximab. That’s one-half too many. There is so much more we need to do. Can we count on your continued generosity this giving season?
|
|
|
Thank you so much for your support of our work!
All my best,
|
|
David Fajgenbaum, MD, MBA, MSc
Co-Founder & President, Castleman Disease Collaborative Network (CDCN)
Founding Director, Center for Cytokine Storm Treatment & Laboratory (CSTL), University of Pennsylvania
|
|
|
|
|
